Financials
- Market Capitalization 396.18 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2840 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.44 USD | -1.32% | -14.14% | +9.66% | -38.77% | 565.21 M USD | ||
| 3024 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.69 USD | -9.52% | -7.16% | -12.00% | +22.58% | 432.60 M USD | ||
| 3175 | QTTB Q32 Bio Inc. - Common Stock | 21.38 USD | +90.72% | +65.48% | +67.29% | +953.20% | 362.53 M USD | ||
| 3324 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.70 USD | -1.21% | -7.72% | -3.92% | -5.53% | 308.25 M USD |
Frequently asked questions about Upstream Bio, Inc. - Common Stock
What is the Upstream Bio, Inc. - Common Stock stock price today?
The current price of Upstream Bio, Inc. - Common Stock (UPB) is 7.28. Over the past 24 hours, the stock has changed by -3.32%. Follow the UPB chart for real-time price dynamics.
What is the stock ticker of Upstream Bio, Inc. - Common Stock?
Upstream Bio, Inc. - Common Stock trades under the ticker UPB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Upstream Bio, Inc. - Common Stock stock going up?
UPB has changed by -2.67% over the last week, +17.61% over the last month, and -38.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Upstream Bio, Inc. - Common Stock net income for the last quarter?
Upstream Bio, Inc. - Common Stock reported net income of -40.59 M for the last quarter. The previous quarter showed -42.46 M, which means net income changed by +4.40%.
How many employees does Upstream Bio, Inc. - Common Stock have?
As of the latest available data, Upstream Bio, Inc. - Common Stock has 75 employees. Workforce size can provide additional context about the company's scale and operations.
What is Upstream Bio, Inc. - Common Stock EBITDA?
Upstream Bio, Inc. - Common Stock EBITDA is -48.54 M, and its EBITDA margin is -4 694.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Upstream Bio, Inc. - Common Stock stock?
You can buy Upstream Bio, Inc. - Common Stock (UPB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Upstream Bio, Inc. - Common Stock stock?
Investing in Upstream Bio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the UPB chart and related analysis on metatrader.com as part of your research.